No abstract available.

No abstract available.

No abstract available.
Prescriptions*

No abstract available.

No abstract available.
Therapeutic Equivalency*

The incidence of primary lung cancer is increasing in our country. This presentation is an attempt to correlate a useful diagnosis with radiological findings of primary lung cancer. Histologically proved 210 cases of primary lung cancer are as follow: Epidermoid Ca. 65%, Adeno Ca. 18%, Small cell Ca. 9.5%, Large cell Ca. 2%, Unclassified Ca. 3.3%, Mucoepidermoid Ca. 2.4%, Mixed Ca. 0.5%. 3. In smoking history; 91% of epidermoid Ca, 17%of small cell Ca. 30% of adeno Ca. has smoking history. 4. In mass size; Average diameter of mass was most was5.3cm. Hilar mass was seen in 48 cases. Hilar mass was most frequent finding in small cell Ca. and the peripheral mass in adeno Ca. 5. Cavitary lung Ca. was 26 cases (12.4%) and most cases had relative thick wall and its mean thickness was 3.6mm. 6. Coexistence of pulmonary tuberculosis and lung cancer was 22 cases (10.5%), and most common in epidermoid cell Ca. as 16 cases. 7. Other findings include metastasis to lymph node, bone and other organ, and pleural effusion.
Diagnosis ; Incidence ; Lung Neoplasms ; Lung ; Lymph Nodes ; Neoplasm Metastasis ; Pleural Effusion ; Smoke ; Smoking ; Tuberculosis, Pulmonary

No abstract available.
Pharmacology, Clinical

Captopril tablets of two different producers were tested for bioequivalence as well as therapeutic equivalence. The pharmacokinetics, the time course of plasma angiotensin-converting enzyme inhibition, and the changes of systolic and diastolic blood pressure after administration of drugs were studied. In a balanced, randomized two-way crossover design, two single doses of 50mg each of captopril were administered orally to twelve male volunteers. Peak blood levels of free captopril were observed about 0.85 hour after the dose, and practically free captopril could not be detected in blood within 8 hours. Peak free captopril levels of both compounds were almost identical(Capoten(R), 464.3ng/ml ; Capril(R), 504.6ng/ml). No statistically significant difference was identified between two compounds when area und the concentration time curve, peak level, time to peak were compared. Inhibition of plasma angiotensin-converting enzyme to blood free captopril concentration showed the hyperbolic concentration-response relationship with IC50 value of 7.4ng/ml. The area under the percent angiotensin-converting enzyme inhibition versus time curve were quite similar after administration of both drugs. The compounds were also found to be equivalent on the premise that no significant difference was detected when the time courses of systolic and diastolic blood pressure reduction were compared.
Biological Availability* ; Blood Pressure ; Captopril* ; Cross-Over Studies ; Humans ; Inhibitory Concentration 50 ; Male ; Pharmacokinetics ; Plasma* ; Tablets* ; Therapeutic Equivalency ; Volunteers

No abstract available.
Peritoneal Dialysis, Continuous Ambulatory* ; Pharmacokinetics* ; Renal Dialysis*

No abstract available.
Korea ; Pharmacology, Clinical*